Literature DB >> 19858774

Modern trends in mortality from meningococcal disease in Australia.

Daniel Simpkins1, Nicholas Wood, Jane Jelfs, Peter B McIntyre, Robert Menzies, Glenda Lawrence, Robert Booy.   

Abstract

Between 1979 and 2006, there were 610 deaths recorded as due to meningococcal disease in Australia. Mortality rates per capita consistently increased on average by 6% per annum between 1979 and 2002, but then fell significantly in 2003, coinciding with the introduction of the meningococcal C conjugate vaccine. In 2002, the mortality rate was 0.24 per 100,000. In the 4 years since, it fell progressively to 0.06 per 100,000. Since the introduction of conjugate Hib and pneumococcal vaccines, meningococcal disease has emerged as the number 1 infectious cause of death in children but conjugate meningococcal C vaccine appears to have greatly reduced total meningococcal disease deaths.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19858774     DOI: 10.1097/INF.0b013e3181accde8

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  3 in total

1.  The accuracy of clinical symptoms and signs for the diagnosis of serious bacterial infection in young febrile children: prospective cohort study of 15 781 febrile illnesses.

Authors:  Jonathan C Craig; Gabrielle J Williams; Mike Jones; Miriam Codarini; Petra Macaskill; Andrew Hayen; Les Irwig; Dominic A Fitzgerald; David Isaacs; Mary McCaskill
Journal:  BMJ       Date:  2010-04-20

2.  Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.

Authors:  David Pace; Ameneh Khatami; Jennifer McKenna; Danielle Campbell; Simon Attard-Montalto; Jacqueline Birks; Merryn Voysey; Catherine White; Adam Finn; Emma Macloed; Saul N Faust; Alison Louise Kent; Paul T Heath; Ray Borrow; Matthew D Snape; Andrew J Pollard
Journal:  BMJ       Date:  2015-04-01

3.  Multidisciplinary analysis of invasive meningococcal disease as a framework for continuous quality and safety improvement in regional Australia.

Authors:  Kathryn A Taylor; David N Durrheim; Tony Merritt; Peter Massey; John Ferguson; Nick Ryan; Carolyn Hullick
Journal:  BMJ Open Qual       Date:  2018-02-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.